cyclophosphamide - Generic mfg.
Proleukin (aldesleukin) - Iovance Biotherap
fludarabine IV - Generic mfg.
E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers (clinicaltrials.gov) - Oct 7, 2026 - P1/2 | N=15 | Recruiting | Sponsor: Christian Hinrichs | Trial completion date: Oct 2026 ➔ Oct 2028 | Trial primary completion date: Oct 2026 ➔ Oct 2028 
Trial completion date • Trial primary completion date • Anal Carcinoma • Cervical Adenocarcinoma • Cervical Cancer • Genito-urinary Cancer • Gynecologic Cancers • Head and Neck Cancer • Oncology • Oropharyngeal Cancer • Penile Cancer • Solid Tumor • Squamous Cell Carcinoma • Squamous Cell Carcinoma of Head and Neck • Vaginal Cancer • Vulvar Cancer
http://clinicaltrials.gov/ct2/show/NCT05639972
 
Oct 7, 2026
 
Prev Next